دورية أكاديمية
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer
| العنوان: | A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer |
|---|---|
| المؤلفون: | Rustin, G., Vergote, I., Micha, J.P., Duska, L.R., Reed, N., Bendell, J., Spitz, D., Dark, G., Hoch, U., Tagliaferri, M., Hannah, A.L., Garcia, A.A. |
| المصدر: | In Gynecologic Oncology November 2017 147(2):276-282 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2017.08.026 |